Table: Sapporo Clinical Lab -2022/23 group results

Sapporo Clinical Laboratory

12/05/2023 07:30

May 12 (Reuters)- 
          Sapporo Clinical Laboratory Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2023    Mar 31, 2022   Mar 31, 2024     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           20.13           19.11          19.56         9.46    
               (+5.3 pct)      (+9.2 pct)     (-2.8 pct)    (-5.1 pct) 
  Operating        1.01            1.54         541 mln      191 mln   
               (-34.4 pct)     (+34.6 pct)    (-46.3 pct)  (-61.1 pct) 
  Recurring        1.16            1.61         486 mln      161 mln   
               (-27.8 pct)     (+35.1 pct)    (-58.0 pct)  (-72.5 pct) 
  Net
  Net            568 mln           1.04         307 mln       82 mln   
               (-45.5 pct)     (+31.4 pct)    (-45.9 pct)  (-68.1 pct) 
  EPS          170.53 yen      306.16 yen      92.28 yen    24.54 yen  
  Ann Div       23.00 yen       23.00 yen      23.00 yen               
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div       23.00 yen       23.00 yen      23.00 yen               
  
  NOTE - Sapporo Clinical Laboratory Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T